Apos Medical UK Limited
Other human health activities · London
ActiveUnited KingdomIncorporated 2010Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2024-12-31
IXBRL · 97 source facts · 20 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 97 source facts · 20 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 48
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2601_07405164_20241231
- Source archive
- Accounts_Monthly_Data-January2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 113 source facts · 21 selected values
Validation findingsXBRL valid
Accounts to 2023-12-31
IXBRL · 113 source facts · 21 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- complete
- Numeric facts
- 61
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3500_07405164_20231231
- Source archive
- Accounts_Monthly_Data-January2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2022-12-31
IXBRL · 116 source facts · 21 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 116 source facts · 21 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 61
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_1766_07405164_20221231
- Source archive
- Accounts_Monthly_Data-February2024.zip
Accounts to 2020-12-31
IXBRL · 126 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 126 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 65
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0101_07405164_20201231
- Source archive
- Accounts_Monthly_Data-January2022.zip
Accounts to 2019-12-31
IXBRL · 140 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2019-12-31
IXBRL · 140 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2019-01-01 to 2019-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 78
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0089_07405164_20191231
- Source archive
- Accounts_Monthly_Data-April2021.zip
Registered details
07405164- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2010-10-12
- Jurisdiction
- —
- Registered office
- 843, FINCHLEY ROAD, LONDON, NW11 8NA, ENGLAND
Classification
1 SIC codes86900
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
1 matched grantsEnabling non invasive treatment of musculoskeletal pathologies in a new remote healthcare worldInnovate UK · Collaborative R&D · 2020-11-01 – 2021-06-30 · with 1 other participant£127,944awarded
Enabling non invasive treatment of musculoskeletal pathologies in a new remote healthcare world
Innovate UK · Collaborative R&D · 2020-11-01 – 2021-06-30 · with 1 other participant
£127,944
awarded
Apos Medical UK Limited£127,944